<DOC>
	<DOCNO>NCT01684345</DOCNO>
	<brief_summary>The purpose study evaluate efficacy gevokizumab treatment active non-infectious intermediate , posterior , pan- uveitis .</brief_summary>
	<brief_title>Safety Efficacy Study Gevokizumab Treat Active Non-infectious Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<criteria>Diagnosis noninfectious intermediate , posterior , pan uveitis least one eye Active uveitic disease least one eye Currently one follow stable treatment regimen uveitis : oral corticosteroid ; systemic immunosuppressive medication ; combination oral corticosteroid least one systemic immunosuppressive medication Effective contraceptive measure Infectious uveitis masquerade syndrome Isolated anterior uveitis Contraindication mydriatic History allergic anaphylactic reaction monoclonal antibody Active tuberculosis disease History recurrent infection predisposition infection ; active ocular infection Pregnant nursing woman Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>Non-infectious Uveitis</keyword>
	<keyword>Intermediate Uveitis</keyword>
	<keyword>Posterior Uveitis</keyword>
	<keyword>Panuveitis</keyword>
</DOC>